TransMedics (TMDX) EBITDA Margin Growth (1y) (2019 - 2026)
Powered by 
Analysis
TransMedics (TMDX) EBITDA Margin Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -497.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 314.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 124.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 670.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 546.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 264.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -919.00 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 595.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 146.00 |
| 10 | TransMedics | 2.98 Bn | 2.51 Bn | 113.20 Mn | -1,074.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,074.00 |
| Mar 31, 2026 | -1,147.00 |
| Dec 31, 2025 | 613.00 |
| Sep 30, 2025 | 1,259.00 |
| Jun 30, 2025 | 1,229.00 |
| Mar 31, 2025 | 629.00 |
| Dec 31, 2024 | 390.00 |
| Sep 30, 2024 | 4,626.00 |
| Jun 30, 2024 | 1,267.00 |
| Mar 31, 2024 | 1,785.00 |
| Dec 31, 2023 | 2,481.00 |
| Sep 30, 2023 | -2,107.00 |
| Jun 30, 2023 | 4,576.00 |
| Mar 31, 2023 | 5,397.00 |
| Dec 31, 2022 | 11,096.00 |
| Sep 30, 2022 | 19,502.00 |
| Jun 30, 2022 | 6,637.00 |
| Mar 31, 2022 | 2,620.00 |
| Dec 31, 2021 | -5,526.00 |
| Sep 30, 2021 | -15,879.00 |